Causes of Death by Disease Stage
| Disease Stage and Causes . | Tacrolimus . | Cyclosporine . | P Value* . |
|---|---|---|---|
| Nonadvanced disease | N = 36 (%) | N = 43 (%) | .99 |
| GVHD (%) | 9 (25) | 13 (30) | |
| Infection (%) | 6 (17) | 7 (16) | |
| Regimen-related toxicity (%)4-151 | 11 (30) | 11 (26) | |
| Relapse (%) | 8 (22) | 9 (21) | |
| Others (%) | 2 (6) | 3 (7) | |
| Advanced disease | N = 53 (%) | N = 28 (%) | .05 |
| GVHD (%) | 3 (6) | 6 (21) | |
| Infection (%) | 10 (19) | 4 (14) | |
| Regimen-related toxicity (%)4-151 | 15 (28) | 2 (7) | |
| Relapse (%) | 22 (41) | 15 (54) | |
| Others (%) | 3 (6) | 1 (4) |
| Disease Stage and Causes . | Tacrolimus . | Cyclosporine . | P Value* . |
|---|---|---|---|
| Nonadvanced disease | N = 36 (%) | N = 43 (%) | .99 |
| GVHD (%) | 9 (25) | 13 (30) | |
| Infection (%) | 6 (17) | 7 (16) | |
| Regimen-related toxicity (%)4-151 | 11 (30) | 11 (26) | |
| Relapse (%) | 8 (22) | 9 (21) | |
| Others (%) | 2 (6) | 3 (7) | |
| Advanced disease | N = 53 (%) | N = 28 (%) | .05 |
| GVHD (%) | 3 (6) | 6 (21) | |
| Infection (%) | 10 (19) | 4 (14) | |
| Regimen-related toxicity (%)4-151 | 15 (28) | 2 (7) | |
| Relapse (%) | 22 (41) | 15 (54) | |
| Others (%) | 3 (6) | 1 (4) |
*By Fisher's exact test.
Patients with venocclusive disease of the liver were included.